@aptussteve

[CellCentric @CellCentric]

Thank you ApconiX. CCS1477 successfully steered through pre-clin tox; onward to the clinic.

[Immunocore @Immunocore]

Did you know that #uvealmelanoma is very different from skin melanoma? RT to help educate. #eyecancer #ocularmelanoma #OcularMelanomaNoMore #MelanomaAwarenessMonth

[@aptussteve @SteveMcConchie]

Great to see progress - good luck in https://t.co/IwT4HXUy1n

[CellCentric @CellCentric]

CCS1477 first-in-class p300/CBP inhibitor for prostate (CRPC) and other cancers

[Immunocore @Immunocore]

Immunocore CEO Eliot Forster, chair of MedCity, tells audiences at the annual #JPMorgan Healthcare Conference in San Francisco that 2018 will be a breakthrough year for genomics, led by the UK https://t.co/mhbE4qBUee

[Immunocore @Immunocore]

CEO Eliot Forster was interviewed by @PharmaScrip on the UK Life Sciences Industrial Strategy announced on 30 August https://t.co/vob403m5lP

[@aptussteve @SteveMcConchie]

https://t.co/isZIleVLWH

[@aptussteve @SteveMcConchie]

BBC News - Chief medical officer calls for gene testing revolution https://t.co/isZIleVLWH

[@aptussteve @SteveMcConchie]

https://t.co/MA0huWHNSo

[@aptussteve @SteveMcConchie]

BBC News - Chief medical officer calls for gene testing revolution https://t.co/isZIleVLWH

[Immunocore @Immunocore]

CEO Eliot Forster highlights the positive results from our Phase I trial in #uveal #melanoma @thetimes https://t.co/JsBfXf37cy

[Immunocore @Immunocore]

Dr Sato explains the positive results from our Phase I trial with #IMCgp100 in #uveal #melanoma at yesterday's poster session #ASC017

[Boyds @boydconsultants]

Great video from the @CTCatapult - Growing a global advanced therapy industry in the UK https://t.co/qJTzgzfZnT #genetherapy

[@aptussteve @SteveMcConchie]

I'm attending International Cancer Cluster Showcase – BIO 2017 https://t.co/hsfGrk5hBq #constantcontact

[ApconiX @ApconiXLtd]

CRUK are rebuilding after the devastating fire. We wish them well! https://t.co/HRfAlXQFld

[@aptussteve @SteveMcConchie]

https://t.co/6Va9UT84Ps

[OBI Pharma @OBIPharma]

Learn more about OBI's Immuno-oncology treatment at ESMO https://t.co/PgyWcm5iLp

[Immunocore @Immunocore]

Proud to win Private UK Life Science Company and UK Life Science CEO of the Year Awards at @BiotechandMoney 2016

[Boston University @BU_Tweets]

BU joins @HHSGov, int'l partners in the fight against #AntibioticResistance with @CARB_X: https://t.co/Z1AMC5ubaq

[CARB-X @CARB_X]

Introducing CARB-X, one of the world’s largest public-private partnerships focused on tackling #antibioticresistance https://t.co/DZJ0CQiik2

[Bionow @Bionow]

U.S. and UK form global partnership to speed new antibiotics https://t.co/WdFUqe1Bmt via @Reuters @TheAMRCentre @wellcometrust